All 1 Debates between Baroness Neville-Jones and Lord Taverne

Drugs: Classification

Debate between Baroness Neville-Jones and Lord Taverne
Tuesday 9th November 2010

(14 years, 1 month ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Taverne Portrait Lord Taverne
- Hansard - - - Excerpts



To ask Her Majesty’s Government whether, in the light of the recent report from the Independent Scientific Committee on Drugs on the harmful effects of different classified and non-classified drugs, they will reconsider the present system of classification.

Baroness Neville-Jones Portrait The Minister of State, Home Office (Baroness Neville-Jones)
- Hansard - -

My Lords, the Government do not intend to review the drug classification system established by the Misuse of Drugs Act 1971. The criminal justice system expects—and the Government must provide—a stable and enduring system. The current system continues to serve that purpose.

Lord Taverne Portrait Lord Taverne
- Hansard - - - Excerpts

My Lords, this recent report is perhaps the most thorough analysis of the impact of different drugs not only on users but on others in society at large. If the Government believe in evidence-based policy, is it not obvious that, in light of this report and of many other reports that have reached similar conclusions, the present classification—with ecstasy in class A and cannabis in class B—is in no way based on evidence of either the physical or social impact of drugs?

Will the Government further accept that they would be utterly irresponsible and failing in their duty to society if they did not provide much stronger disincentives to the indulgence of the abuse of alcohol, which comes top—by miles—of all other drugs in its impact on society as a whole?

Baroness Neville-Jones Portrait Baroness Neville-Jones
- Hansard - -

My Lords, on the whole question of drugs classification, there is clearly no consensus about what constitutes evidence. The Government simply do not agree that a system of a sliding scale of harms, such as is suggested in the Nutt report, constitutes a good basis for government policy. We do not believe that structuring drug-harm classifications in the way that the recent report does would be better than the current basis for government policy.